St. Jude Draws Warning Letter For Off-label Promotion Of A-Fib Ablation
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical has removed Epicor LP cardiac ablation system marketing materials from its website to address a recent FDA warning letter alleging off-label promotion of the device to treat atrial fibrillation
You may also be interested in...
DoJ Targets Five Cardiac Ablation Device Makers In False Claims Probe
Medtronic, Boston Scientific, St. Jude Medical and AtriCure are targeted in an ongoing Justice Department probe into alleged off-label promotion of cardiac ablation devices for atrial fibrillation
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.